| 000 | 018260000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025225.0 | ||
| 008 | 080420s2008 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.04.Ph.D.2008.Ay.E | ||
| 100 | 0 | _aAyman Ahmed Rasmy | |
| 245 | 1 | 0 |
_aEvaluation of cd38 , b - 2 M and LDH as prognostic factors in cll patients and correlate them with clinical stage and response to chemotherapy / _cAyman Ahmed Rasmy ; Supervised Mostafa M.Elserafi , Ibrahim A.Ibrahim , Amr Elsayd Zaher |
| 246 | 1 | 5 | _aتقييم سي دي 38 وبيتا - 2 ميكروجلوبلين وال.دي اتش كعوامل متابعة في مرضي سرطان الدم الليمفاوي المزمن ودراسة علاقتهم مع المرحلة المرضية ولاستجابة للعلاج الكيماوي |
| 260 |
_aCairo : _bAyman Ahmed Rasmy , _c2008 |
||
| 300 |
_a228P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Oncology | ||
| 520 | _aCll is a model for failed programmed cell death or apoptosis.the two most commonly used staging systems were rai and binet.the prognosis of a cll patient depends on complex relationships between the characteristics of the patient , the disease as well as sensitivity of the disease to treatment. | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCD38 | |
| 653 | 4 | _aChronic lymphocytic leukemia "CLL" | |
| 653 | 4 | _aPrognostic factors | |
| 700 | 0 |
_aAmr Elsayd Zaher , _eSupervisor |
|
| 700 | 0 |
_aIbrahim A.Ibrahim , _eSupervisor |
|
| 700 | 0 |
_aMostafa M.Elserafi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAzza _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c8357 _d8357 |
||